Skip to main content

MultiPlan Providing its Members Access to Response Genetics' MDx Tests

NEW YORK (GenomeWeb News) – Response Genetics today announced an agreement with managed healthcare firm MultiPlan to provide its members with access to Response's molecular diagnostic tests.

MultiPlan has about 67 million consumers accessing its provider network products, and it contracts with more than 900,000 healthcare providers across the US, Response said.

Today's deal is the third announced recently by Response with a payor, following agreements with Blue Cross Blue Shield of Illinois in July and Blue Shield of California in May. The Los Angeles-based company last week announced a 39 percent jump in revenues for its second quarter.

Financial and other details of the agreement with MultiPlan were not disclosed.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.